Inventor
JOHN TYHONAS
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds41%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
PatentTitleYear
12,331,039Inhibitors of fibroblast growth factor receptor kinases202512,312,336Inhibitors of RAF kinases202511,814,384Inhibtors of Raf kinases202311,407,737Inhibitors of RAF kinases202211,390,618Inhibitors of cyclin-dependent kinases202211,345,681Inhibitors of fibroblast growth factor receptor kinases202211,197,858Substituted amines for treating cardiac diseases2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to CARDURION PHARMACEUTICALS LLC (1)· patent assignee history
2021–2025Based in US· patent location history
2022–2023Patents assigned to KINNATE BIOPHARMA INC (4)· patent assignee history
2025Patents assigned to KHORA SPV 1 LLC (1)· patent assignee history
2025Patents assigned to PF MEDICAMENT (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KINNATE BIOPHARMA INC | 4 | 2022–2023 |
| CARDURION PHARMACEUTICALS LLC | 1 | 2021 |
| KHORA SPV 1 LLC | 1 | 2025 |
| PF MEDICAMENT | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2025 |